APA (7th ed.) Citation

Zheng, Y., Shen, H., Xu, L., Feng, J., Tang, H., Zhang, N., . . . Gao, G. Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials. Wiley.

Chicago Style (17th ed.) Citation

Zheng, Yanhua, Hongyuan Shen, Li Xu, Juan Feng, Hailong Tang, Na Zhang, Xiequn Chen, and Guangxun Gao. Monoclonal Antibodies Versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide Plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials. Wiley.

MLA (9th ed.) Citation

Zheng, Yanhua, et al. Monoclonal Antibodies Versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide Plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials. Wiley.